AI assistant aims to ease thyroid cancer anxiety before surgery

NCT ID NCT07690839

Not yet recruiting Symptom relief Sponsor: Cedars-Sinai Medical Center Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study tests whether an online educational tool called THRIVE, powered by artificial intelligence, can help people newly diagnosed with thyroid cancer feel less anxious and more confident about their treatment choices. Participants use the tool on their own device before meeting with their surgeon. The goal is to see if this approach reduces thyroid-cancer-related anxiety and improves shared decision-making.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: THRIVE AI educational agent
What this could lead to: If effective, this approach could reduce anxiety and help patients make more informed treatment decisions before surgery.
What could go wrong: This is a small pilot study (60 people) testing feasibility, so results may not be generalizable. The AI tool may not significantly reduce anxiety or improve decision quality.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAPILLARY THYROID CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thyroid cancer thyroid gland papillary carcinoma Thyroid Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

THYROID CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.